INmune Bio reports 2025 financial results, plans regulatory filings
Go back to INmune Bio reports 2025 financial results, plans regulatory filings| (NASDAQ: INMB) | Delayed: 1.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.43 | EPS | $ | |||
| Volume | 6,250 | |||||

